CMH :: Clinical and Molecular Hepatology

Robotic versus laparoscopic liver resection for liver malignancy: a systematic review and meta-analysis of propensity score-matched studies

Zhang-tao Long, Hua-jian Li, Hao Liang, Ya-chen Wu, Sajid Ameer, Xi-lin Qu, Zhi-qiang Xiang, Qian Wang, Xiao-ming Dai, Zhu Zhu

Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination

Yingliang Wang, Shuguang Ju, Huimin Zhou, Yaowei Bai, Chen Zhou, Jiacheng Liu, Xiangjun Dong, Chuansheng Zheng

International Journal of Nanomedicine.2024; Volume 19: 137. CrossRef

Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations

Seyedeh Panid Madani, Mohammad Mirza‐Aghazadeh‐Attari, Alireza Mohseni, Timothy Pawlik, Ihab R. Kamel

Journal of Surgical Oncology.2023; 127(3): 385. CrossRef

Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals

Ginny Jacobs, Deborah A. Boyle, Hashem B. El‐Serag, Robert J. Lewandowski, Stacey M. Stein, Patrice Lazure, Pam McFadden

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Sven H. Loosen, Markus S. Jördens, Berenike Schoon, Gerald Antoch, Tom Luedde, Peter Minko, Christina Loberg, Christoph Roderburg

Journal of Cancer Research and Clinical Oncology.2023; 149(9): 6181. CrossRef

Longitudinal ultrasound imaging and network modeling in rats reveal sex-dependent suppression of liver regeneration after resection in alcoholic liver disease

Benjamin K. Barnhart, Toshiki Kan, Ankita Srivastava, Corinne E. Wessner, John Waters, Manju Ambelil, John R. Eisenbrey, Jan B. Hoek, Rajanikanth Vadigepalli

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study

Su Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim

Journal of Liver Cancer.2023; 23(1): 166. CrossRef

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma

Nozipho Nyakale, Luca Filippi, Colleen Aldous, Mike Sathekge

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib

Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, Seokhwi Kim, Young Bae Kim, Su Bin Lim, Won Park, Tae Wook Kang, Geum Ok Baek, Moon Gyeong Yoon, Ju A Son, Ji Hyang Weon, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong

C4orf47 is a Novel Prognostic Biomarker and Correlates with Infiltrating Immune Cells in Hepatocellular Carcinoma

Hye-Ran Kim, Choong Won Seo, Sang Jun Han, Jongwan Kim

Biomedical Science Letters.2023; 29(1): 11. CrossRef

Progress in bioprinting technology for tissue regeneration

Alireza Sabzevari, Hossein Rayat Pisheh, Mojtaba Ansari, Amir Salati

Journal of Artificial Organs.2023; 26(4): 255. CrossRef

A Comprehensive Narrative Review on the History, Current Landscape, and Future Directions of Hepatocellular Carcinoma (HCC) Systemic Therapy

Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review

Pragati Rai, Mohammed Yusuf Ansari, Mohammed Warfa, Hammad Al‐Hamar, Julien Abinahed, Ali Barah, Sarada Prasad Dakua, Shidin Balakrishnan

Predicting the prognosis of liver cancer patients based on cell differentiation trajectory and application of nanomaterials in treatment

Ximei XU, Zhikun ZHANG, Qiaoying CHEN, Tao WU, Wei SHI, Lu GAN, Xiuli LIU, Runzhe LIU, Yong HUANG, Ruirui ZHANG, Yongxiang ZHAO, Pan WU, Liping ZHONG, Jian HE

Chest wall mass as a sign of ignored hepatocellular carcinoma in an alcoholic cirrhotic patient: a case report

Elisha Poddar, Suraj Shrestha, Raju Thapa, Sudhan Subedi, Niharika Pathak, Ramesh Khadayat, Pradeep Regmi

Annals of Medicine & Surgery.2023; 85(8): 4092. CrossRef

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report

Chan-Ran Park, Hye-Ri Bae, Ga-Young Lee, Chang-Gue Son, Jung-Hyo Cho, Chong-Kwan Cho, Nam-Hun Lee

Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions

Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee

Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance

Saein Kim, Sunghwan Yoo, Jung Il Lee, Sora Kim, Hye Young Chang, Dokyun Kim, Seok Hoon Jeong, Kwan Sik Lee, Hyun Woong Lee

Digestive Diseases and Sciences.2022; 67(1): 321. CrossRef

Outcomes of robotic‐assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma

Linh M. Duong, Hui Cai, Martha J. Shrubsole, Christina E. Bailey, Kamran Idrees, Xiao‐Ou Shu

Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression

Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang

International Journal of Hyperthermia.2022; 39(1): 1. CrossRef

Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma

Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen

WIREs Nanomedicine and Nanobiotechnology.2022;[Epub] CrossRef

Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits

Eun Kyung Choe, Manu Shivakumar, Anurag Verma, Shefali Setia Verma, Seung Ho Choi, Joo Sung Kim, Dokyoon Kim

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging

Xiangyi Cao, Yulong Zhang, Qianqian Zhou, Sujing Sun, Minwei He, Xiaohui Wang, Ping Ma, Xiaoang Yang, Liping Lv, Linsheng Zhan

Surgical Resection Is Preferred in Selected Solitary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Jaehun Yang, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients

Sung Joon Kim, Jong Man Kim, Nam-Joon Yi, Gyu-Seong Choi, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh

Annals of Surgical Treatment and Research.2022; 102(3): 131. CrossRef

Practical utility of liver segmentation methods in clinical surgeries and interventions

Mohammed Yusuf Ansari, Alhusain Abdalla, Mohammed Yaqoob Ansari, Mohammed Ishaq Ansari, Byanne Malluhi, Snigdha Mohanty, Subhashree Mishra, Sudhansu Sekhar Singh, Julien Abinahed, Abdulla Al-Ansari, Shidin Balakrishnan, Sarada Prasad Dakua

Medical Treatment for Hepatocellular Carcinoma in Japan

Youichi Kawano, Yohei Kaneya, Yuto Aoki, Masato Yoshioka, Akira Matsushita, Tetsuya Shimizu, Junji Ueda, Hideyuki Takata, Nobuhiko Taniai, Tomohiro Kanda, Atsushi Hirakata, Hideyuki Suzuki, Hiroshi Yoshida

Journal of Nippon Medical School.2022; 89(2): 154. CrossRef

Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment

Nieun Seo, Dong Jin Joo, Mi-Suk Park, Seung-seob Kim, Hye Jung Shin, Yong Eun Chung, Jin-Young Choi, Myoung Soo Kim, Myeong-Jin Kim

Intraarterial Therapies for the Management of Hepatocellular Carcinoma

Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami

Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas

Anne Olbrich, Olga Gros, Sebastian Ebel, Timm Denecke, Holger Gößmann, Nicolas Linder, Florian Lordick, Dirk Forstmeyer, Daniel Seehofer, Robert Sucher, Sebastian Rademacher, Johannes Niemeyer, Madlen Matz-Soja, Thomas Berg, Florian van Bömmel

Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic

Journal of Interventional Medicine.2022; 5(4): 180. CrossRef

Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model

Yingliang Wang, Xuelian He, Chen Zhou, Yaowei Bai, Tongqiang Li, Jiacheng Liu, Shuguang Ju, Chaoyang Wang, Guangya Xiang, Bin Xiong

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network

Dingde Ye, Yaping Liu, Yanuo Chen, Guoqiang Li, Beicheng Sun, Jin Peng, Qingxiang Xu

Contrast-Enhanced Ultrasound Tumor Therapy With Abdominal Imaging Transducer

Ryan G. Morrison, Mrigendra B. Karmacharya, Chandra M. Sehgal

Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing Prognosis

Li Song, Qiankun Li, Yao Lu, Xianqi Feng, Rungong Yang, Shouguo Wang, Muhammad Muddassir Ali

Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study

Chenghao Ge, Mingjie Luo, Kaiyuan Guo, Dong Zhu, Ning Han, Tengjiao Wang, Xiuying Zhao

SAMD13 as a Novel Prognostic Biomarker and its Correlation with Infiltrating Immune Cells in Hepatocellular Carcinoma

Hye-Ran Kim, Choong Won Seo, Jae-Ho Lee, Sang Jun Han, Jongwan Kim

Biomedical Science Letters.2022; 28(4): 260. CrossRef

LI-RADS and transplantation: challenges and controversies

Guilherme M. Cunha, Dorathy E. Tamayo-Murillo, Kathryn J. Fowler

SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)

Ryan D. Hirsch, Chris Mills, Rohit Sawhney, Siddharth Sood, Virginia Bird, Gauri Mishra, Anouk Dev, William Kemp, John Lubel, Stuart K. Roberts, Paul Gow, Amanda J. Nicoll

Journal of Gastrointestinal Cancer.2021; 52(3): 907. CrossRef

Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works

Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma

Jae Seung Lee, Young Eun Chon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Wonseok Kang, Moon Seok Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hwi Young Kim, Tae Hun Kim, Kwon Yoo,

Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

Matteo Donadon, Egesta Lopci, Jacopo Galvanin, Simone Giudici, Daniele Del Fabbro, Ezio Lanza, Vittorio Pedicini, Arturo Chiti, Guido Torzilli

Survival in untreated hepatocellular carcinoma: A national cohort study

Young Ae Kim, Danbee Kang, Hyeyoung Moon, Donghyun Sinn, Minwoong Kang, Sang Myung Woo, Yoon Jung Chang, Boram Park, Sun-Young Kong, Eliseo Guallar, Soo-Yong Shin, Geunyeon Gwak, Joung Hwan Back, Eun Sook Lee, Juhee Cho, Gianfranco D. Alpini

Hyperspectral image-based analysis of thermal damage for ex-vivo bovine liver utilizing radiofrequency ablation

Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Abou-Bakr M. Youssef, Yasser H. El-Sharkawy

Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma

Asmaa Abdel Nabi, Shimaa Attia Atta, Eman El-Ahwany, Emad Elzayat, Hanan Saleh

Molecular Biology Reports.2021; 48(7): 5549. CrossRef

Operator Evaluation of Ultrasound Fusion Imaging Usefulness in the Percutaneous Ablation of Hepatic Malignancies: A Prospective Study

Alessandro Beleù, Alessandro Drudi, Alvise Giaretta, Riccardo De Robertis, Ilaria Fedrigo, Enrico Martone, Conci Simone, Chiara Bovo, Mirko D'Onofrio

Ultrasound in Medicine & Biology.2021; 47(11): 3159. CrossRef

Hepatic patch by stacking patient-specific liver progenitor cell sheets formed on multiscale electrospun fibers promotes regenerative therapy for liver injury

Yohan Kim, Young Won Kim, Seung Bum Lee, Kyojin Kang, Sangtae Yoon, Dongho Choi, Suk-Hee Park, Jaemin Jeong

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma

Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study

Jong Man Kim, Sung Yoo Cho, Jinsoo Rhu, Miyoung Jung, Jung Hyun Her, Okjae Lim, Gyu-Seong Choi, Eui-Cheol Shin, Yu-Kyeong Hwang, Jae-Won Joh

Annals of Hepato-Biliary-Pancreatic Surgery.2021; 25(2): 206. CrossRef

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway

Impact of Tumor Burden Score on Conditional Survival after Curative‐Intent Resection for Hepatocellular Carcinoma: A Multi‐Institutional Analysis

Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfr

World Journal of Surgery.2021; 45(11): 3438. CrossRef

PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line

Theeraphong Pho-iam, Primana Punnakitikashem, Chayapol Somboonyosdech, Sirinapa Sripinitchai, Patarabutr Masaratana, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Chamaiphorn Wongwan, Kytai T. Nguyen, Chatchawan Srisawat

Biochemical and Biophysical Research Communications.2021; 553: 191. CrossRef

Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

Yingliang Wang, Chen Zhou, Jiacheng Liu, Qin Shi, Songjiang Huang, Chongtu Yang, Tongqiang Li, Yang Chen, Bin Xiong

Cancer Management and Research.2021; Volume 13: 6935. CrossRef

Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma

Jing Zhao, Weiran Xu, Yu Zhang, Xiaomin Lv, Yiran Chen, Gaoda Ju, Fang Yang, Li Lin, Xiaosong Rao, Ziwei Guo, Tao Xing, Li Li, Jun Liang

Biomarkers in Medicine.2021; 15(7): 497. CrossRef

A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness

Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng, Pierpaolo Alongi

Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis

Monica M. Matsumoto, Samdeep Mouli, Priyali Saxena, Ahmed Gabr, Ahsun Riaz, Laura Kulik, Daniel Ganger, Haripriya Maddur, Justin Boike, Steven Flamm, Christopher Moore, Aparna Kalyan, Kush Desai, Bartley Thornburg, Michael Abecassis, Ryan Hickey, Juan Cai

CardioVascular and Interventional Radiology.2021; 44(7): 1070. CrossRef

MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma

Precision Medical Sciences.2021; 10(1): 4. CrossRef

Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma

Shengyi Long, Fang Peng, Baohui Song, Liang Wang, Jun Chen, Bingbing Shang

International Journal of General Medicine.2021; Volume 14: 5483. CrossRef

The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma

Shuangchi Liu, Zhiduan Xu, Zhuling Fang, Dengyong Zhang, Zhongqiang Qin, Longfei Fan, Jiakang Duan, Hongxiang Yin, Yigang Zhang, Qing Pang, Yi Tan

International Journal of General Medicine.2021; Volume 14: 4291. CrossRef

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation

Wenxiu Zhao, Lingxiang Jiang, Ting Fang, Fei Fang, Yingchun Liu, Ye Zhao, Yuting You, Hao Zhou, Xiaolin Su, Jiangwei Wang, Sheng Liu, Yaomin Chen, Jun Wan, Xiumei Huang

Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes

Dong Ho Lee, Jing Woong Kim, Jeong Min Lee, Jong Man Kim, Min Woo Lee, Hyunchul Rhim, Young Hoe Hur, Kyung-Suk Suh

Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma

Jong Man Kim, Jae-Won Joh, Nam-Joon Yi, Gyu-Seong Choi, Kyunga Kim, Kwang-Woong Lee, Kyung-Suk Suh

Journal of Gastrointestinal Surgery.2020; 24(10): 2219. CrossRef

Progress in 3D bioprinting technology for tissue/organ regenerative engineering

Ishita Matai, Gurvinder Kaur, Amir Seyedsalehi, Aneesah McClinton, Cato T. Laurencin

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection

Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim

Clinical and Molecular Hepatology.2020; 26(1): 33. CrossRef

LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features

Se Woo Kim, Ijin Joo, Hyo-Cheol Kim, Su Joa Ahn, Hyo-Jin Kang, Sun Kyung Jeon, Jeong Min Lee

Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom

Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer

Effectiveness and feasibility of external beam radiotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium involvement: a multicenter trial in Korea (KROG 17-10)

Chai Hong Rim, Bae-Kwon Jeong, Tae Hyun Kim, Jin Hee Kim, Hyun-Cheol Kang, Jinsil Seong

International Journal of Radiation Biology.2020; 96(6): 759. CrossRef

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis

Sangdeok Shin, Sang Hoon Lee, Minjong Lee, Ji Hyun Kim, Wongu Lee, Hyun Woo Lee, Min Soo Park, Seungwoo Park, Tae Suk Kim, Dae Hee Choi

An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective

Chai Hong Rim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Victor Lee, Zhao-Chong Zeng, Jinsil Seong

Radiotherapy and Oncology.2020; 148: 73. CrossRef

Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry

Jun Sik Yoon, Han Ah Lee, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Young Eun Chon, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Young-Joo Won, Eunyang Kim, Jeong-Hoon Lee

Journal of Liver Cancer.2020; 20(1): 41. CrossRef

Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis

Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding

Clinics and Research in Hepatology and Gastroenterology.2020; 44(6): 845. CrossRef

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment

Zu‐Yau Lin, Jing‐Houng Wang, Ming‐Lun Yeh, Ching‐I Huang, Kwong‐Ming Kee, Yi‐Hao Yen, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang

The Kaohsiung Journal of Medical Sciences.2020; 36(9): 750. CrossRef

Hepatocellular Carcinoma in a Patient With Hepatic Steatosis

ACG Case Reports Journal.2020; 7(5): e00378. CrossRef

Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B

Jeong-Ju Yoo, Su Jong Yu, Bora Lee, Eun Ju Cho, Jeong-Hoon Lee, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon

Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity

Evidence-Based Complementary and Alternative Medicine.2020; 2020: 1. CrossRef

Conditional survival analysis of hepatocellular carcinoma

Mihir M. Shah, Benjamin I. Meyer, Kevin Rhee, Rachel E. NeMoyer, Yong Lin, Ching‐Wei D. Tzeng, Salma K. Jabbour, Timothy J. Kennedy, John L. Nosher, David A. Kooby, Shishir K. Maithel, Darren R. Carpizo

Journal of Surgical Oncology.2020; 122(4): 684. CrossRef

Exosomes derived from chemically induced human hepatic progenitors inhibit oxidative stress induced cell death

Sujin Hyung, Jaemin Jeong, Kyusoon Shin, Ju Young Kim, Ji‐Hye Yim, Chan Jong Yu, Hyun Suk Jung, Kyung‐Gyun Hwang, Dongho Choi, Jong Wook Hong

Biotechnology and Bioengineering.2020; 117(9): 2658. CrossRef

Tissue characterization utilizing hyperspectral imaging for liver thermal ablation

Mohamed Hisham Aref, Ibrahim H. Aboughaleb, Yasser H. El-Sharkawy

Photodiagnosis and Photodynamic Therapy.2020; 31: 101899. CrossRef

Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinoma

Liver Cancer International.2020; 1(2): 41. CrossRef

Long noncoding RNA AC092171.4 promotes hepatocellular carcinoma progression by sponging microRNA-1271 and upregulating GRB2

Chengjun Sun, Shanzhou Huang, Yuchen Hou, Zhongqiu Li, Dongmei Xia, Lishan Zhang, Yixi Zhang, Yifeng Cai, Ziming Wang, Qi Zhou, Xiaoshun He, Linwei Wu

Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Stu

Yao Liu, Yuxin Li, Fangyuan Gao, Qun Zhang, Xue Yang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Wei Li, Xianbo Wang

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study

Anwaar Saeed, Hannah Hildebrand, Robin Park, Mohammed Al-Jumayli, Saqib Abbasi, Tina Melancon, Azhar Saeed, Raed Al-Rajabi, Anup Kasi, Joaquina Baranda, Stephen Williamson, Weijing Sun

Journal of Clinical Medicine.2020; 9(9): 2682. CrossRef

Treatment patterns and direct medical costs among patients with advanced hepatocellular carcinoma

Abdalla Aly, Elisabetta Malangone-Monaco, Virginia Noxon, Caroline Henriques, Fernando Benavente, Amy Kim

Current Medical Research and Opinion.2020; 36(11): 1813. CrossRef

A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population

Jung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, Suhg Namgoong, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Hyoung Doo Shin, Yoon Jun Kim

Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives

Daniel M. Girardi, Jana Priscila M. Pacífico, Fernanda P. L. Guedes de Amorim, Gustavo dos Santos Fernandes, Marcela C. Teixeira, Allan A. L. Pereira

The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma

In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen

Yonsei Medical Journal.2019; 60(2): 140. CrossRef

Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation

Nieun Seo, Myoung Soo Kim, Mi-Suk Park, Jin-Young Choi, Chansik An, Kyunghwa Han, Seung Up Kim, Dong Jin Joo, Myeong-Jin Kim

Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma

Sung-Mi Jung, Jong Man Kim, Gyu-Seong Choi, Choon Hyuck David Kwon, Nam-Joon Yi, Kwang-Woong Lee, Kyung Suk Suh, Jae-Won Joh

Journal of Gastrointestinal Surgery.2019; 23(2): 304. CrossRef

Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells

Yohan Kim, Kyojin Kang, Seung Bum Lee, Daekwan Seo, Sangtae Yoon, Sung Joo Kim, Kiseok Jang, Yun Kyung Jung, Kyeong Geun Lee, Valentina M. Factor, Jaemin Jeong, Dongho Choi

Journal of Surgical Research.2019; 233: 381. CrossRef

Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI

So Hee Song, Woo Kyoung Jeong, Dongil Choi, Young Kon Kim, Hee Chul Park, Jeong Il Yu

Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization

Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park

The Korean Journal of Internal Medicine.2019; 34(6): 1223. CrossRef

Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma

Toshifumi Hoki, Eriko Katsuta, Li Yan, Kazuaki Takabe, Fumito Ito

Journal of Surgical Research.2019; 234: 343. CrossRef

Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC

Dong Ho Lee, Jeong Min Lee, Mi Hye Yu, Bo Yun Hur, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon, Yoon Jun Kim, Jeong-Hoon Lee, Su Jong Yu, Joon Koo Han

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients

Dong Hyun Sinn, Gyu-Seong Choi, Hee Chul Park, Jong Man Kim, Honsoul Kim, Kyoung Doo Song, Tae Wook Kang, Min Woo Lee, Hyunchul Rhim, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Woo Kyoung Jeong, Seong Hyun Kim, Jeong Il Yu, Sang Yun Ha, Su Jin Lee, Ho Yeon

Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series

Daniel Jiahao Wong, Joycelyn Lee, Su Pin Choo, Choon Hua Thng, Tiffany Hennedige

Young‐Sun Lee, Myung Han Hyun, Sun Young Yim, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun

Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy

Shi-Bing Wang, Ying-Yu Ma, Xiao-Yi Chen, Yuan-Yuan Zhao, Xiao-Zhou Mou

Future Liver Remnant Hypertrophy after Portal Vein Embolization Is Inversely Correlated with Intrahepatic Tumor Burden

Edwin A. Takahashi, Chad J. Fleming, James C. Andrews

Journal of Vascular and Interventional Radiology.2019; 30(3): 435. CrossRef

Endoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors

Andrew Lange, Thiruvengadam Muniraj, Harry R. Aslanian

Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 339. CrossRef

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma

Jeong-Ju Yoo, Su Yu, Juri Na, Kyungmin Kim, Young Cho, Yun Lee, Eun Cho, Jeong-Hoon Lee, Yoon Kim, Hyewon Youn, Jung-Hwan Yoon

International Journal of Molecular Sciences.2019; 20(6): 1292. CrossRef

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini

Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis

Jiwoon Choi, Taek Chung, Hyungjin Rhee, Young-Joo Kim, Youngsic Jeon, Jeong Eun Yoo, Songmi Noh, Dai Hoon Han, Young Nyun Park

Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension

Ran Kim, Woo Kyoung Jeong, Tae Wook Kang, Kyoung Doo Song, Min Woo Lee, Soo Hyun Ahn, Hyunchul Rhim

Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma

Zhiyong Sheng, Xiaolin Wang, Geliang Xu, Ge Shan, Liang Chen

Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma

Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data

Jun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, Hyo Young Lee, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Thomas Yau, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Yoon-Koo Kang, Ming-Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo

The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease

H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér

Scandinavian Journal of Gastroenterology.2019; 54(6): 746. CrossRef

Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis

David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim

Digestive Diseases and Sciences.2019; 64(12): 3660. CrossRef

Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression

Yu Young Joo, Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations

Won Hyeok Choe, Ki Jeong Kim, So Young Lee, Yu Min Choi, So Young Kwon, Jeong Han Kim, Bum Joon Kim

World Journal of Gastroenterology.2019; 25(33): 4985. CrossRef

A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status

Hyo Jung Cho, Soon Sun Kim, So Young Kang, Min Jae Yang, Choong Kyun Noh, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Sung Won Cho, Jae Youn Cheong

Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population

Laura Bainy Rodrigues de Freitas, Larisse Longo, Deivid Santos, Ivana Grivicich, Mário Reis Álvares-da-Silva

World Journal of Hepatology.2019; 11(9): 689. CrossRef

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon

Journal of Liver Cancer.2019; 19(2): 128. CrossRef

Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis

Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim

Scandinavian Journal of Gastroenterology.2019; 54(10): 1283. CrossRef

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database

Jae Seung Lee, In Rae Cho, Hye Won Lee, Mi Young Jeon, Tae Seop Lim, Oidov Baatarkhuu, Do Young Kim, Kwang-Hyub Han, Jun Yong Park

Cancer Research and Treatment.2019; 51(4): 1347. CrossRef

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Loosen, Schulze-Hagen, Bruners, Tacke, Trautwein, Kuhl, Luedde, Roderburg

In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) Cells

Biomedical and Pharmacology Journal.2019; 12(2): 901. CrossRef

Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma

Xidan Zhu, Hui Yu, Baolin Li, Jing Quan, Zhangrui Zeng, Guangrong Li, Jinbo Liu

Interleukin‑8 promotes cell migration via CXCR1 and CXCR2 in liver cancer

Huijuan Bi, Yu Zhang, Shanshan Wang, Wenhao Fang, Wenjun He, Lina Yin, Ying Xue, Zhixiang Cheng, Minghui Yang, Jilu Shen

Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma

Isabelle Durot, Rosa M.S. Sigrist, Nishita Kothary, Jarrett Rosenberg, Jürgen K. Willmann, Ahmed El Kaffas

Clinical Cancer Research.2019; 25(22): 6683. CrossRef

Young‐Sun Lee, Myung Han Hyun, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun

The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity

Jae Hyun Park, Dong Hwi Kim, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik, In Su Hong

World Journal of Surgery.2018; 42(5): 1514. CrossRef

18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment

Pil Soo Sung, Hye Lim Park, Keungmo Yang, Seawon Hwang, Myeong Jun Song, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ie Ryung Yoo, Si Hyun Bae

European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(3): 384. CrossRef

Contrast-enhanced ultrasound of malignant liver lesions

Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann

Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly

Digestive and Liver Disease.2018; 50(11): 1115. CrossRef

Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Soon Sun Kim, Hyo Jung Cho, Ji Sun Nam, Hyun Ji Kim, Dae Ryong Kang, Je Hwan Won, Jinoo Kim, Jai Keun Kim, Jei Hee Lee, Bo Hyun Kim, Mi Young Lee, Sung Won Cho, Jae Youn Cheong

Journal of Korean Medical Science.2018;[Epub] CrossRef

Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance

Chung Seop Lee, Yong Jin Jung, Soon Sun Kim, Jae Youn Cheong, Ga Ram Lee, Han Gyeol Kim, Beom Hee Kim, Jung Wha Chung, Eun Sun Jang, Sook-Hyang Jeong, Kyung Ho Lee, Jin-Wook Kim, Ferruccio Bonino

Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic population

Bo Hyun Kim, Young‐Suk Lim, Eun‐Yang Kim, Hyun‐Joo Kong, Young‐Joo Won, Seungbong Han, Sohee Park, Jae Seok Hwang

Journal of Gastroenterology and Hepatology.2018; 33(2): 475. CrossRef

Prolongation of liver-specific function for primary hepatocytes maintenance in 3D printed architectures

Yohan Kim, Kyojin Kang, Sangtae Yoon, Ji Sook Kim, Su A. Park, Wan Doo Kim, Seung Bum Lee, Ki-Young Ryu, Jaemin Jeong, Dongho Choi

High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016

Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr

World Journal of Hepatology.2018; 10(1): 116. CrossRef

Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization

Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi

Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef

ALBI versus Child‐Pugh grading systems for liver function in patients with hepatocellular carcinoma

Seong K. Na, Sun Y. Yim, Sang J. Suh, Young K. Jung, Ji H. Kim, Yeon S. Seo, Hyung J. Yim, Jong E. Yeon, Kwan S. Byun, Soon H. Um

Journal of Surgical Oncology.2018; 117(5): 912. CrossRef

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B

Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim

Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma

Jong Man Kim, Nam-Joon Yi, Choon Hyuck David Kwon, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh

Annals of Surgical Treatment and Research.2018; 94(3): 129. CrossRef

Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

Y. E. Chon, K. S. Jung, M.‐J. Kim, J.‐Y. Choi, C. An, J. Y. Park, S. H. Ahn, B. K. Kim, S. U. Kim, H. Park, S. K. Hwang, K. S. Rim, K.‐H. Han, D. Y. Kim

Alimentary Pharmacology & Therapeutics.2018; 47(8): 1201. CrossRef

Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein

Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon

Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?

Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Scandinavian Journal of Gastroenterology.2018; 53(6): 727. CrossRef

Alpha-fetoprotein in pericardial, peritoneal, and pleural fluids: A body fluid matrix evaluation

William E. Owen, Joshua J.H. Hunsaker, Jonathan R. Genzen

Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma

Yuri Jeong, Jinhong Jung, Byungchul Cho, Jungwon Kwak, Chiyoung Jeong, Jong Hoon Kim, Jin-hong Park, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon

Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells

Jiao Li, Dan-Dan Wu, Ji-Xiang Zhang, Jing Wang, Jing-Jing Ma, Xue Hu, Wei-Guo Dong

World Journal of Gastroenterology.2018; 24(17): 1901. CrossRef

Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade

Hajime Matsushima, Yuko Takami, Tomoki Ryu, Munehiro Yoshitomi, Masaki Tateishi, Yoshiyuki Wada, Hideki Saitsu

Journal of Gastrointestinal Surgery.2018; 22(7): 1230. CrossRef

Hepatocellular Carcinoma: Review of Targeted and Immune Therapies

Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes

Journal of Gastrointestinal Cancer.2018; 49(3): 227. CrossRef

Post-operative care of interventional therapy for 40 liver cancer patients with obstructive jaundice

European Journal of Cancer Care.2018; 27(4): e12858. CrossRef

Percutaneous US/MRI Fusion–guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes

Kyoung Doo Song, Min Woo Lee, Hyunchul Rhim, Tae Wook Kang, Dong Ik Cha, Dong Hyun Sinn, Hyo Keun Lim

Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA–Enhanced Magnetic Resonance Images

Jinhong Jung, Hojin Kim, Sang Min Yoon, Byungchul Cho, Yeon Joo Kim, Jungwon Kwak, Jong Hoon Kim

International Journal of Radiation Oncology*Biology*Physics.2018; 102(4): 867. CrossRef

Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?

Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho

Cancer Chemotherapy and Pharmacology.2018; 82(3): 469. CrossRef

Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer

Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu

Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy

Techniques in Vascular and Interventional Radiology.2018; 21(4): 205. CrossRef

Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer

Chai Hong Rim, Sangjoon Park, Joong Yeol Woo, Jinsil Seong

Strahlentherapie und Onkologie.2018; 194(11): 1017. CrossRef

Hepatocellular carcinoma treatment: hurdles, advances and prospects

Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera

Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular Carcinoma

Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi

Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration

Sumin Lee, Hojin Kim, Yunseo Ji, Byungchul Cho, Su Ssan Kim, Jinhong Jung, Jungwon Kwak, Jin-hong Park, Sang-wook Lee, Jong Hoon Kim, Sang Min Yoon

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Jongmoo Park, Jinhong Jung, Daegeun Kim, In-Hye Jung, Jin-hong Park, Jong Hoon Kim, Sang-wook Lee, Sang Min Yoon

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification

Minjong Lee, Young Chang, Sohee Oh, Young Youn Cho, Dhong-Eun Jung, Hong Hyun Kim, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Dong Ho Lee, Jeong Min Lee, Jung-Hwan Yoon, Kyung-Suk Suh, Yoon Jun Kim

A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma

Yao Liu, Le Sun, Fangyuan Gao, Xue Yang, Yuxin Li, Qun Zhang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Ying Feng, Yuyong Jiang, Xianbo Wang

Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future

World Journal of Gastroenterology.2018; 24(46): 5215. CrossRef

Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis

Guo Tian, Shigui Yang, Jinqiu Yuan, Diane Threapleton, Qiyu Zhao, Fen Chen, Hongcui Cao, Tian’an Jiang, Lanjuan Li

MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2

Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang

International Journal of Molecular Medicine.2018;[Epub] CrossRef

The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells

Huihui Li, Yichang Fan, Fan Yang, Lei Zhao, Bangwei Cao

Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013–2015

Monica L. Kasting, Anna R. Giuliano, Richard R. Reich, Richard G. Roetzheim, David R. Nelson, Elizabeth Shenkman, Susan T. Vadaparampil

Cancer Epidemiology, Biomarkers & Prevention.2018; 27(4): 503. CrossRef

Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice

Euroasian Journal of Hepato-Gastroenterology.2018; 8(1): 83. CrossRef

Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area

Jung Ho Im, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Jeong Il Yu, Tae Hyun Kim, Jun Won Kim, Taek‐Keun Nam, Kyubo Kim, Hong Seok Jang, Jin Hee Kim, Mi‐Sook Kim, Won Sup Yoon, Inkyung Jung, Jinsil Seong

Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver

Hyo Jung Cho, Bohyun Kim, Jung-Dong Lee, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho

American Journal of Gastroenterology.2017; 112(3): 460. CrossRef

Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment

Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee Jung Wang, Bong Wan Kim, Jung-Dong Lee, Dae Yong Kang, Ji Hyun Kim, Yang Min Jae, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong

Clinics and Research in Hepatology and Gastroenterology.2017; 41(2): 181. CrossRef

Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma

Sung-Ling Tang, Meng-Yi Bai, Jyun-Yi Wang, Po-Da Hong

Colloids and Surfaces B: Biointerfaces.2017; 151: 304. CrossRef

Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis

Jeong Eun Yoo, Young-Joo Kim, Hyungjin Rhee, Haeryoung Kim, Ei Yong Ahn, Jin Sub Choi, Massimo Roncalli, Young Nyun Park, Taro Yamashita

Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area

Dong Hyeon Lee, Jeong-Hoon Lee, Yong Jin Jung, Jungsoo Gim, Won Kim, Byeong Gwan Kim, Kook Lae Lee, Yuri Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu

Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure

Yohan Kim, Kyojin Kang, Jaemin Jeong, Seung Sam Paik, Ji Sook Kim, Su A Park, Wan Doo Kim, Jisun Park, Dongho Choi

Annals of Surgical Treatment and Research.2017; 92(2): 67. CrossRef

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE

Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi

Clinical and Molecular Hepatology.2017; 23(1): 42. CrossRef

Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133

Wonhee Hur, Jae Yong Ryu, Hyun Uk Kim, Sung Woo Hong, Eun Byul Lee, Sang Yup Lee, Seung Kew Yoon

Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis

A model predicting survival of patients with recurrent or progressive hepatocellular carcinoma: the MORE score

Sang Il Choi, Ami Yu, Bo Hyun Kim, Eun Jeong Ko, Soon Seob Park, Byung‐Ho Nam, Joong‐Won Park

Journal of Gastroenterology and Hepatology.2017; 32(3): 651. CrossRef

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells

Minjong Lee, Ara Jo, Seulki Lee, Jong Bin Kim, Young Chang, Joon Yeul Nam, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Yuan-Soon Ho

Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years

J.G. Park, S.Y. Park, W.Y. Tak, Y.O. Kweon, S.Y. Jang, Y.R. Lee, K. Hur, H.J. Lee, H.W. Lee

Chibuzo Iloabuchi, Amanda Stover, Pragya Rai, Yifan Zhang, Khalid M. Kamal

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma

Shin Ok Jeong, Eui Bae Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Dong Erk Goo, Su Yeon Park

Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma

Yonsei Medical Journal.2017; 58(4): 737. CrossRef

Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation

Elisabeth G. Klompenhouwer, Raphaëla C. Dresen, Chris Verslype, Annouschka Laenen, Gert De Hertogh, Christophe M. Deroose, Lawrence Bonne, Vincent Vandevaveye, Geert Maleux

CardioVascular and Interventional Radiology.2017; 40(12): 1882. CrossRef

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding

Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?

Andrej Khandoga, Moritz Drefs, Markus Schoenberg, Tobias Schiergens, Katharina Frenes, Mark op den Winkel, Christoph Trumm, Martin K. Angele, Markus Guba, Jens Werner, Markus Rentsch

European Journal of Gastroenterology & Hepatology.2017; 29(9): 1045. CrossRef

Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study

Tae Won Choi, Jeong Min Lee, Dong Ho Lee, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Joon Koo Han

Korean Journal of Radiology.2017; 18(5): 799. CrossRef

Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma

Seung Kak Shin, Yun Soo Kim, Young Sup Shim, Seung Joon Choi, So Hyun Park, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim

Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective anal

Sung Won Lee, Hae Lim Lee, Nam Ik Han, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Therapeutic Advances in Medical Oncology.2017; 9(10): 615. CrossRef

Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma

Jennifer Eatrides, Emilie Wang, Nishi Kothari, Richard Kim

Cancer Control.2017; 24(3): 107327481772924. CrossRef

Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion

Ezio Lanza, Matteo Donadon, Paolo Felisaz, Antonio Mimmo, Arturo Chiti, Guido Torzilli, Luca Balzarini, Egesta Lopci

Nuclear Medicine Communications.2017; 38(10): 826. CrossRef

Liver Function Assessment Using Albumin–Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation

In Soo Oh, Dong Hyun Sinn, Tae Wook Kang, Min Woo Lee, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Digestive Diseases and Sciences.2017; 62(11): 3235. CrossRef

Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma

Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi

Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma

Jung Wha Chung, Eun Sun Jang, Jaihwan Kim, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Kyung Ho Lee, Jin-Wook Kim

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results

High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma

In-Hye Jung, Sang Min Yoon, Jungwon Kwak, Jin-Hong Park, Si Yeol Song, Sang-Wook Lee, Seung Do Ahn, Eun Kyung Choi, Jong Hoon Kim

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria

Yuri Cho, Jeong-Hoon Lee, Dong Hyeon Lee, Eun Ju Cho, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Yoon Jun Kim, Jung-Hwan Yoon, Kyung-Suk Suh

Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study

Ji Hae Nahm, Hyungjin Rhee, Haeryoung Kim, Jeong Eun Yoo, Jee San Lee, Youngsic Jeon, Gi Hong Choi, Young Nyun Park

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy

In Rae Cho, Hye Won Lee, Ki Jun Song, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Jinsil Seong, Kwang-Hyub Han, Jun Yong Park

Hepatocellular carcinoma: Implications for Asia-Pacific Oncology Nurses

Asia-Pacific Journal of Oncology Nursing.2017; 4(2): 98. CrossRef

Comparison of laparoscopic liver resection for hepatocellular carcinoma located in the posterosuperior segments or anterolateral segments: A case-matched analysis

Woohyung Lee, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi, Hong Kyung Shin, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon

Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon

Biomedicine & Pharmacotherapy.2016; 83: 607. CrossRef

Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma

Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan, Hon-Yi Lin

Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria

Jung Hee Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Ki Yeon Kim, Kyunga Kim, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B

Yuri Cho, Dong Hyun Sinn, Su Jong Yu, Geum Youn Gwak, Ji Hoon Kim, Yang Jae Yoo, Dae Won Jun, Tae Yeob Kim, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu